Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Emory University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Emory University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Emory University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Emory University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Emory University, Medical Devices Deals, 2011 to YTD 2017 10
Emory University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Emory University, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Empire Genomics Enters Into Licensing Agreement With Emory University For Genomic Biomarkers 13
AKESOgen and Emory University School of Medicine Enter into Partnership 14
Medibio Enters into Agreement with Emory University 15
Defense Threat Reduction Agency Enters into Contract with Emory University 16
Spotlight Innovation Enters into Research Agreement with Emory University 17
Emory University And Children’s Hospital of Philadelphia Enter Into Co-Development Agreement With Harvard University 18
NextBio Enters Into Research Agreement With Emory University And Aflac Cancer Center For Medulloblastoma Biomarkers 19
Emory University Enters Into Joint Venture With UniQuest To Form Que Oncology 20
NextBio Enters Into Agreement With Winship Cancer Institute of Emory University For Myeloma Biomarkers 21
Bristol-Myers Squibb Enters Into Co-Development Agreement With Emory University 22
Rockland Immunochemicals Enters Into An Agreement With Emory University 23
Licensing Agreements 24
Cocrystal Pharma Enters into Licensing Agreement with Duke University and Emory University 24
Meissa Vaccines Enters into Agreement with Emory University for Rhinovirus Vaccine 26
Meissa Vaccines Enters into Agreement with Emory University for RSV Vaccine Technologies 27
Incysus Enters into Licensing Agreement with Emory University, Children’s Hospital of Atlanta and University of Alabama at Birmingham 28
Cambium Medical Technologies Enters into Licensing Agreement with Emory University 29
Cocrystal Pharma Enters into Licensing Agreement with Emory University 30
Clearside Biomedical Enters into Licensing Agreement with Emory University and GTRC 31
Carrick Therapeutics Enters into Licensing Agreement with Emory University 32
Genomind Enters Into Licensing Agreement With Emory University 33
RayBiotech Enters Into Licensing Agreement With Emory University 34
Metaclipse Therapeutics Enters Into Option For License Agreement With Emory University 35
Acquisition 36
Eurofins Scientific Acquires 75% Stake in Emory Genetics Lab for USD40 Million 36
Emory University – Key Competitors 37
Emory University – Key Employees 38
Emory University – Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Joint Venture 41
Recent Developments 42
Government and Public Interest 42
Sep 25, 2017: Georgia Clinical Translational Science Alliance receives $51 million NIH state-wide grant 42
Sep 07, 2017: NIH awards nearly $100 million for Autism Centers of Excellence program 45
Aug 29, 2017: Morehouse School of Medicine Joins the NIH All of Us Research Consortium 47
Aug 25, 2017: Study identifies genes linked to better immune response to flu vaccine 48
Aug 24, 2017: Lower blood pressure targets for older adults may offer cognitive benefits, study suggests 49
Aug 23, 2017: Cancer drug discovery: Targeting DNA repair 50
Jan 20, 2017: South African Study Provides Compelling New Evidence on Role of Person-to Person Transmission in Drug-Resistant TB Epidemics 51
Nov 16, 2016: Antiviral Success Makes Some Immune Cells Strikier 52
Jun 07, 2016: NIH Awards Emory $35.6 Million Grant for Research Aimed at HIV/AIDS Vaccine and Cure 53
Mar 29, 2016: Three-stage delivery of platinum-based cluster bombs against cancer 54
Feb 09, 2016: Cigna Foundation Makes Community Health Navigation A U.S. Priority; Announces World Of Difference Grant To Emory University, Atlanta 55
Jan 12, 2016: New NIH awards will support development of therapeutic alternatives to traditional antibiotics 56
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58
Emory University, Pharmaceuticals & Healthcare, Key Facts 2
Emory University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Emory University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Emory University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Emory University, Deals By Therapy Area, 2011 to YTD 2017 9
Emory University, Medical Devices Deals, 2011 to YTD 2017 10
Emory University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Empire Genomics Enters Into Licensing Agreement With Emory University For Genomic Biomarkers 13
AKESOgen and Emory University School of Medicine Enter into Partnership 14
Medibio Enters into Agreement with Emory University 15
Defense Threat Reduction Agency Enters into Contract with Emory University 16
Spotlight Innovation Enters into Research Agreement with Emory University 17
Emory University And Children's Hospital of Philadelphia Enter Into Co-Development Agreement With Harvard University 18
NextBio Enters Into Research Agreement With Emory University And Aflac Cancer Center For Medulloblastoma Biomarkers 19
Emory University Enters Into Joint Venture With UniQuest To Form Que Oncology 20
NextBio Enters Into Agreement With Winship Cancer Institute of Emory University For Myeloma Biomarkers 21
Bristol-Myers Squibb Enters Into Co-Development Agreement With Emory University 22
Rockland Immunochemicals Enters Into An Agreement With Emory University 23
Cocrystal Pharma Enters into Licensing Agreement with Duke University and Emory University 24
Meissa Vaccines Enters into Agreement with Emory University for Rhinovirus Vaccine 26
Meissa Vaccines Enters into Agreement with Emory University for RSV Vaccine Technologies 27
Incysus Enters into Licensing Agreement with Emory University, Children’s Hospital of Atlanta and University of Alabama at Birmingham 28
Cambium Medical Technologies Enters into Licensing Agreement with Emory University 29
Cocrystal Pharma Enters into Licensing Agreement with Emory University 30
Clearside Biomedical Enters into Licensing Agreement with Emory University and GTRC 31
Carrick Therapeutics Enters into Licensing Agreement with Emory University 32
Genomind Enters Into Licensing Agreement With Emory University 33
RayBiotech Enters Into Licensing Agreement With Emory University 34
Metaclipse Therapeutics Enters Into Option For License Agreement With Emory University 35
Eurofins Scientific Acquires 75% Stake in Emory Genetics Lab for USD40 Million 36
Emory University, Key Competitors 37
Emory University, Key Employees 38
Emory University, Subsidiaries 40
Emory University, Joint Venture 41